Purine derivatives as liver X receptor agonists
US7495004B2 · kind B2 · utility
2Cited by
20References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2003 |
| Grant date | Feb 24, 2009 |
| Priority date | — |
| Expiry date | Nov 21, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods for the treatment or prevention of an LXR mediated disease or condition, including cardiovascular disease and atherosclerosis, novel compounds of formula (I) for use in such methods and pharmaceutical compositions comprising compounds for use in such methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.